These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24192123)

  • 1. Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions.
    Ono C; Kikkawa H; Suzuki A; Suzuki M; Yamamoto Y; Ichikawa K; Fukae M; Ieiri I
    Pharmacogenomics; 2013 Nov; 14(14):1745-64. PubMed ID: 24192123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG.
    Brian W; Tremaine LM; Arefayene M; de Kanter R; Evers R; Guo Y; Kalabus J; Lin W; Loi CM; Xiao G
    Pharmacogenomics; 2016 Apr; 17(6):615-31. PubMed ID: 27045656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
    Ieiri I; Takane H; Hirota T; Otsubo K; Higuchi S
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):651-74. PubMed ID: 17014387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
    Cascorbi I
    Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
    Bruhn O; Cascorbi I
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatment.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Cancer Treat Rev; 2009 Feb; 35(1):18-31. PubMed ID: 18771857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.
    Gerloff T
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):69-77. PubMed ID: 14598019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications.
    Yiannakopoulou ECh
    Pharmacogenomics J; 2013 Apr; 13(2):105-9. PubMed ID: 23044602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnogeographic and inter-individual variability of human ABC transporters.
    Xiao Q; Zhou Y; Lauschke VM
    Hum Genet; 2020 May; 139(5):623-646. PubMed ID: 32206879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of variants in ATP-binding cassette transporters on breast cancer treatment.
    Xiao Q; Zhou Y; Lauschke VM
    Pharmacogenomics; 2020 Dec; 21(18):1299-1310. PubMed ID: 33222659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
    Jabir RS; Naidu R; Annuar MA; Ho GF; Munisamy M; Stanslas J
    Pharmacogenomics; 2012 Dec; 13(16):1979-88. PubMed ID: 23215890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
    De Mattia E; Toffoli G; Polesel J; D'Andrea M; Corona G; Zagonel V; Buonadonna A; Dreussi E; Cecchin E
    Pharmacogenet Genomics; 2013 Oct; 23(10):549-57. PubMed ID: 24018773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of cytochromes P450 in tropical medicine.
    Ribeiro V; Cavaco I
    Curr Drug Targets; 2006 Dec; 7(12):1709-19. PubMed ID: 17168845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer pharmacogenomics: implications on ethnic diversity and drug response.
    Patel JN
    Pharmacogenet Genomics; 2015 May; 25(5):223-30. PubMed ID: 25751395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.
    Umamaheswaran G; Kumar DK; Adithan C
    Indian J Med Res; 2014 Jan; 139(1):27-65. PubMed ID: 24604039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pharmacogenetics in irinotecan therapy.
    de Jong FA; de Jonge MJ; Verweij J; Mathijssen RH
    Cancer Lett; 2006 Mar; 234(1):90-106. PubMed ID: 16343744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of genetic polymorphisms in drug transporters for pharmacotherapy.
    Kerb R
    Cancer Lett; 2006 Mar; 234(1):4-33. PubMed ID: 16504381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.